Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Neurology
|
February 9, 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study
Raquel Pinheiro Barbosa, Caroline Moreau, Anne Sophie Rolland, et al.
Plos One
|
January 7, 2021
Personality dimensions of patients can change during the course of parkinson's disease
Mathilde Boussac, Christophe Arbus, Julia Dupouy, et al.
Journal of Parkinson'S Disease
|
July 24, 2022
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?
Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, et al.
Journal of Parkinson'S Disease
|
December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)
Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 27, 2011
Singular DYT6 phenotypes in association with new THAP1 frameshift mutations
Arnaud Blanchard, Agathe Roubertie, Marion Simonetta-Moreau, et al.
BMJ Neurology Open
|
January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysis
Aymeric Lanore, Marion Houot, Aymeric Basset, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 17, 2018
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease
Florence Cormier-Dequaire, Samir Bekadar, Mathieu Anheim, et al.
Movement Disorders Clinical Practice
|
September 1, 2025
Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease
Clément Desjardins, Stéphan Grimaldi, Sheng Luo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)
Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 5, 2024
Amantadine use in the French prospective NS-Park cohort
Margherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Neurology
|
February 9, 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study
Raquel Pinheiro Barbosa, Caroline Moreau, Anne Sophie Rolland, et al.
Plos One
|
January 7, 2021
Personality dimensions of patients can change during the course of parkinson's disease
Mathilde Boussac, Christophe Arbus, Julia Dupouy, et al.
Journal of Parkinson'S Disease
|
July 24, 2022
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?
Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, et al.
Journal of Parkinson'S Disease
|
December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)
Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 27, 2011
Singular DYT6 phenotypes in association with new THAP1 frameshift mutations
Arnaud Blanchard, Agathe Roubertie, Marion Simonetta-Moreau, et al.
BMJ Neurology Open
|
January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysis
Aymeric Lanore, Marion Houot, Aymeric Basset, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 17, 2018
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease
Florence Cormier-Dequaire, Samir Bekadar, Mathieu Anheim, et al.
Movement Disorders Clinical Practice
|
September 1, 2025
Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease
Clément Desjardins, Stéphan Grimaldi, Sheng Luo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)
Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 5, 2024
Amantadine use in the French prospective NS-Park cohort
Margherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Page
of 6